O. Wittenberg

Percutaneous Treatment of Chronically Occluded Internal Mammary Artery Grafts: A Utopia?

Marie-Jeanne Bertrand, F. Barbou, O. Wittenberg, 2020 .

Relationship between post‐treatment platelet reactivity and ischemic and bleeding events at 1‐year follow‐up in patients receiving prasugrel

G. Lemesle, M. Pansieri, L. Maillard, 2012, Journal of thrombosis and haemostasis : JTH.

Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.

P. Fabbro-Péray, B. Ledermann, A. Polge, 1999, The American journal of cardiology.

Usefulness and clinical impact of a fractional flow reserve and angiographic targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry.

M. Gilard, E. Teiger, L. Feldman, 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes.

M. Pansieri, L. Maillard, L. Bonello, 2011, Journal of the American College of Cardiology.

Primary stenting with abciximab in acute myocardial infarction complicated by cardiogenic shock (the ADMIRAL trial)

P. Barragan, G. Montalescot, F. Paganelli, 2002 .

Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.

D. Carrié, N. Delarche, F. Schiele, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.

P. Barragan, L. Bonello, F. Paganelli, 2008, Journal of the American College of Cardiology.

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

P. Barragan, G. Montalescot, Gilles Montalescot, 2001 .

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

M. Morice, P. Barragan, G. Montalescot, 2001, The New England journal of medicine.

French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.

G. Finet, M. Morice, J. Fajadet, 2012, Archives of cardiovascular diseases.

Initial and follow-up results of the European Seaquence coronary stent registry.

E. Fleck, C. Macaya, P. Brunel, 2004, Journal of interventional cardiology.

Emergency percutaneous angioplasty of unprotected left main coronary artery in the setting of myocardial infarction: experience of a low volume center without surgical back up.

L. Bonello, F. Paganelli, P. Sbragia, 2006, International journal of cardiology.

CORONARY INTERVENT IONS

N. Delarche, L. Bonello, O. Wittenberg, 2014 .